(Q68447410)

English

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

scientific article published on 01 February 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

title

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

author name string

L M Hondeghem

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

language of work or name

English

0 references

publication date

1 February 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

volume

81

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

page(s)

686-690

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

Identifiers

DOI

10.1161/01.CIR.81.2.686

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 September 2019

PubMed publication ID

2153477

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2153477

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2153477%20AND%20SRC:MED&resulttype=core&format=json

(Q68447410)

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)